Mærke: Life Sciences

Aktiekursudvikling

WntResearch: Closer Than Ever

Case: WntResearch Closer than ever WntResearch has applied for their phase II trials regarding proof-of-concept for the FOXT-5 compound. Hence, WntResearch is closer than ever

Læs mere »

Del indlægget på sociale media eller på email. 

LinkedIn
Facebook
Twitter
Email